Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PLEURAL MESOTHELIOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 388 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Simsir, A; Fetsch, P; Bedrossian, CWM; Ioffe, OB; Abati, A
      Absence of SV-40 large T antigen (Tag) in malignant mesothelioma effusions: An immunocytochemical study

      DIAGNOSTIC CYTOPATHOLOGY
    2. Fetsch, PA; Simsir, A; Abati, A
      Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology

      DIAGNOSTIC CYTOPATHOLOGY
    3. Yu, GH; Soma, L; Hahn, S; Friedberg, JS
      Changing clinical course of patients with malignant mesothelioma: Implications for FNA cytology and utility of immunocytochemical staining

      DIAGNOSTIC CYTOPATHOLOGY
    4. Weiser, TS; Guo, ZS; Ohnmacht, GA; Parkhurst, ML; Tong-On, P; Marincola, FM; Fischette, MR; Yu, XD; Chen, GA; Hong, JA; Stewart, JH; Nguyen, DM; Rosenberg, SA; Schrump, DS
      Sequential 5-aza-2 '-deoxycytidine-depsipeptide FR901228 treatment inducesapoptosis preferentially in cancer cells and facilitates their recognitionby cytolytic T lymphocytes specific for NY-ESO-1

      JOURNAL OF IMMUNOTHERAPY
    5. Jasani, B; Jones, CJ; Radu, C; Wynford-Thomas, D; Navabi, H; Mason, M; Adams, M; Gibbs, A
      Simian virus 40 detection in human mesothelioma: Reliability and significance of the available molecular evidence

      FRONTIERS IN BIOSCIENCE
    6. Khokhar, NZ; She, Y; Rusch, VW; Sirotnak, FM
      Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: Further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums

      CLINICAL CANCER RESEARCH
    7. Gabrielson, EW; Pinn, ML; Testa, JR; Kuhajda, FP
      Increased fatty acid synthase is a therapeutic target in mesothelioma

      CLINICAL CANCER RESEARCH
    8. Marsh, GM; Gula, MJ; Youk, AO; Buchanich, JM; Churg, A; Colby, TV
      Historical cohort study of US man-made vitreous fiber production workers: II. Mortality from mesothelioma

      JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    9. Strickler, HD; Goedert, JJ; Butel, JS; Daniel, R; Freymuth, F; Gibbs, A; Griffiths, DJ; Jablons, D; Jasani, B; Jones, C; Lednicky, JA; Miller, CW; Radu, C; Richards, WG; Shah, KV; You, L; Corson, JM; Gerwin, B; Harris, C; Sugarbaker, DJ; Egan, W; Lewis, AM; Krause, PR; Peden, K; Levine, AS; Melnick, S; Cosentino, M; da Costa, M; Devairrakam, V; Ji, J; Palefsky, J; Rasmussen, L; Shea, K; Wacholder, S; Waters, D; Wright, T
      A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    10. Testa, JR; Giordano, A
      SV40 and cell cycle perturbations in malignant mesothelioma

      SEMINARS IN CANCER BIOLOGY
    11. Jasani, B; Cristaudo, A; Emri, SA; Gazdar, AF; Gibbs, A; Krynska, B; Miller, C; Mutti, L; Radu, C; Tognon, M; Procopio, A
      Association of SV40 with human tumours

      SEMINARS IN CANCER BIOLOGY
    12. Rizzo, P; Bocchetta, M; Powers, A; Foddis, R; Stekala, E; Pass, HI; Carbone, M
      SV40 and the pathogenesis of mesothelioma

      SEMINARS IN CANCER BIOLOGY
    13. Schrump, DS; Waheed, I
      Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas

      SEMINARS IN CANCER BIOLOGY
    14. Imperiale, MJ; Pass, HI; Sanda, MG
      Prospects for an SV40 vaccine

      SEMINARS IN CANCER BIOLOGY
    15. Metheny-Barlow, LJ; Flynn, B; van Gijssel, HE; Marrogi, A; Gerwin, BI
      Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma - Antiproliferative effects in vitro and tumorigenicstimulation in vivo

      AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    16. Katano, K; Tsujitani, S; Maeta, M; Fukuda, K; Oka, S; Hisamitsu, K; Ikeguchi, M; Kaibara, N
      Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer

      ONCOLOGY REPORTS
    17. Maggi, G; Casadio, C; Cianci, R; Rena, O; Ruffini, E
      Trimodality management of malignant pleural mesothelioma

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    18. Vivo, C; Levy, F; Pilatte, Y; Fleury-Feith, J; Chretien, P; Monnet, I; Kheuang, L; Jaurand, MC
      Control of cell cycle progression in human mesothelioma cells treated withgamma interferon

      ONCOGENE
    19. Mohiuddin, M; Cao, XB; Fang, BL; Nishizaki, M; Smythe, WR
      Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma

      CANCER GENE THERAPY
    20. Mukherjee, S; Nelson, D; Loh, S; van Bruggen, I; Palmer, LJ; Leong, C; Garlepp, MJ; Robinson, BWS
      The immune anti-tumor effects of GM-CSF and B7-1 gene transfection are enhanced by surgical debulking of tumor

      CANCER GENE THERAPY
    21. Steele, JPC; O'Doherty, CA; Shamash, J; Evans, MT; Gower, NH; Tischkowitz, MD; Rudd, RM
      Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma

      ANNALS OF ONCOLOGY
    22. Dumortier, P; Gocmen, A; Laurent, K; Manco, A; De Vuyst, P
      The role of environmental and occupational exposures in Turkish immigrantswith fibre-related disease

      EUROPEAN RESPIRATORY JOURNAL
    23. Ravenel, JG; McAdams, HP; Remy-Jardin, M; Remy, J
      Multidimensional imaging of the thorax

      JOURNAL OF THORACIC IMAGING
    24. Velders, MP; Macedo, MF; Provenzano, M; Elmishad, AG; Holzhutter, HG; Carbone, M; Kast, WM
      Human T cell responses to endogenously presented HLA-A*0201 restricted peptides of simian virus 40 large T antigen

      JOURNAL OF CELLULAR BIOCHEMISTRY
    25. Pujolar, AE; Gonzalez, C; Agudo, A; Calleja, A; Beltran, M; Gonzalez-Moya, J; Hernandez, S; Panades, R; Ramirez, J; Turuguet, D
      Information about occupational exposure to asbestos given to cases in an etiological study: Ethical aspects

      EUROPEAN JOURNAL OF EPIDEMIOLOGY
    26. Jaklitsch, MT; Grondin, SC; Sugarbaker, DJ
      Treatment of malignant mesothelioma

      WORLD JOURNAL OF SURGERY
    27. McLaren, BR; Whitaker, D; Robinson, BWS; Lake, RA
      Expression and integrity of DNA topoisomerase II isoforms does not explaingeneric drug resistance in malignant mesothelioma

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    28. Neumann, V; Gunther, S; Muller, KM; Fischer, M
      Malignant mesothelioma - German mesothelioma register 1987-1999

      INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
    29. Soini, Y; Puhakka, A; Kahlos, K; Saily, M; Paakko, P; Koistinen, P; Kinnula, V
      Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1

      HISTOPATHOLOGY
    30. Beer, TW; Shepherd, P; Pullinger, NC
      p27 immunostaining is related to prognosis in malignant mesothelioma

      HISTOPATHOLOGY
    31. King, JE; Hasleton, PS
      Immunohistochemistry and the diagnosis of malignant mesothelioma

      HISTOPATHOLOGY
    32. David, H; Mendoza, S; Konishi, T; Miller, CW
      Simian virus 40 is present in human lymphomas and normal blood

      CANCER LETTERS
    33. Knuuttila, A; Kivisaari, L; Kivisaari, A; Palomaki, M; Tervahartiala, P; Mattson, K
      Evaluation of pleural disease using MR and CT - With special reference to malignant pleural mesothelioma

      ACTA RADIOLOGICA
    34. Rodelsperger, K; Jockel, KH; Pohlabeln, H; Romer, W; Woitowitz, HJ
      Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: Results from a German hospital-based case-control study

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    35. Minor, PD; Dunn, G; Pipkin, PA
      Detection and growth kinetics of SV40 preparations with different enhancerelement copy number

      VACCINE
    36. Ceresoli, GL; Locati, LD; Ferreri, AJM; Cozzarini, C; Passoni, P; Melloni, G; Zannini, P; Bolognesi, A; Villa, E
      Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma

      LUNG CANCER
    37. Kosty, MP; Herndon, JE; Vogelzang, NJ; Kindler, HL; Green, MR
      High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study - Cancer and Leukemia Group B 9631

      LUNG CANCER
    38. Kindler, HL; Millard, F; Herndon, JE; Vogelzang, NJ; Suzuki, Y; Green, MR
      Gemcitabine for malignant mesothelioma: A phase II trial by the cancer andleukemia group B

      LUNG CANCER
    39. Sandberg, AA; Bridge, JA
      Updates on the cytogenetics and molecular genetics of bone and soft tissuetumors. Mesothelioma

      CANCER GENETICS AND CYTOGENETICS
    40. Miettinen, M; Limon, J; Niezabitowski, A; Lasota, J
      Calretinin and other mesothelioma markers in synovial sarcoma - Analysis of antigenic similarities and differences with malignant mesothelioma

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    41. Davidson, B; Nielsen, S; Christensen, J; Asschenfeldt, P; Berner, A; Risberg, B; Johansen, P
      The role of desmin and N-cadherin in effusion cytology - A comparative study using established markers of mesothelial and epithelial cells

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    42. Carella, R; Deleonardi, G; D'Errico, A; Salerno, A; Egarter-Vigl, E; Seebacher, C; Donazzan, G; Grigioni, WF
      Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma - A study with logistic regression analysis

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    43. Magnani, C; Dalmasso, P; Biggeri, A; Ivaldi, C; Mirabelli, D; Terracini, B
      Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: A case-control study in Casale Monferrato,Italy

      ENVIRONMENTAL HEALTH PERSPECTIVES
    44. Wiggins, J
      Statement on malignant mesothelioma in the United Kingdom

      THORAX
    45. Farmer, CKT; Goldsmith, DJA
      Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma

      POSTGRADUATE MEDICAL JOURNAL
    46. Cacciotti, P; Libener, R; Betta, P; Martini, F; Porta, C; Procopio, A; Strizzi, L; Penengo, L; Tognon, M; Mutti, L; Gaudino, G
      SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    47. Strizzi, L; Catalano, A; Vianale, G; Orecchia, S; Casalini, A; Tassi, G; Puntoni, R; Mutti, L; Procopio, A
      Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma

      JOURNAL OF PATHOLOGY
    48. Kouhata, T; Fukuyama, K; Hagihara, N; Tabuchi, K
      Detection of simian virus 40 DNA sequence in human primary glioblastomas multiforme

      JOURNAL OF NEUROSURGERY
    49. Roberts, F; McCall, AE; Burnett, RA
      Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry

      JOURNAL OF CLINICAL PATHOLOGY
    50. Kettunen, E; Nissen, AM; Ollikainen, T; Taavitsainen, M; Tapper, J; Mattson, K; Linnainmaa, K; Knuutila, S; El-Rifai, W
      Gene expression profiling of malignant mesothelioma cell lines: cDNA arraystudy

      INTERNATIONAL JOURNAL OF CANCER
    51. Schouwink, H; Rutgers, ET; van der Sijp, J; Oppelaar, H; van Zandwijk, N; van Veen, R; Burgers, S; Stewart, FA; Zoetmulder, F; Baas, P
      Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma - Dose finding and toxicity results

      CHEST
    52. Odaka, M; Sterman, DH; Wiewrodt, R; Zhang, Y; Kiefer, M; Amin, KM; Gao, GP; Wilson, JM; Barsoum, J; Kaiser, LR; Albelda, SM
      Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity

      CANCER RESEARCH
    53. Lozano, MD; Panizo, A; Toledo, GR; Sola, JJ; Pardo-Mindan, J
      Immunocytochemistry in the differential diagnosis of serous effusions - A comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears

      CANCER CYTOPATHOLOGY
    54. Thylen, A; Hjerpe, A; Martensson, G
      Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma

      CANCER
    55. Kahlos, K; Soini, Y; Sormunen, R; Kaarteenaho-Wiik, R; Paakko, P; Linnainmaa, K; Kinnula, VL
      Expression and prognostic significance of catalase in malignant mesothelioma

      CANCER
    56. Browne, K; Wagner, JC
      Environmental exposure to amphibole-asbestos and mesothelioma

      CANADIAN MINERALOGIST
    57. Mohr, S; Rihn, B
      Profiling gene expression in human mesothelioma cells using DNA microarrayand high-density filter array technologies

      BULLETIN DU CANCER
    58. Carroll-Pankhurst, C; Engels, E; Strickler, HD; Goedert, JJ; Wagner, J; Mortimer, EA
      Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period

      BRITISH JOURNAL OF CANCER
    59. Edwards, JG; Cox, G; Andi, A; Jones, JL; Walker, RA; Waller, DA; O'Byrne, KJ
      Angiogenesis is an independent prognostic factor in malignant mesothelioma

      BRITISH JOURNAL OF CANCER
    60. Foster, MR; Johnson, JE; Olson, SJ; Allred, C
      Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1in malignant mesotheliomas and primary pulmonary adenocarcinomas

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    61. Murai, Y
      Malignant mesothelioma in Japan: Analysis of registered autopsy cases

      ARCHIVES OF ENVIRONMENTAL HEALTH
    62. Kidney, BA; Haines, DM; Ellis, JA; Burnham, ML; Jackson, ML
      Evaluation of formalin-fixed paraffin-embedded tissues from vaccine site-associated sarcomas of cats for polyomavirus DNA and antigen

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    63. Barth, Z; Kohler, B
      An unusual cause of malignant ascites - Peritoneal mesothelioma - Reply

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    64. Barth, Z; Thiele, H; Frenzel, H; Kohler, B
      Peritoneal mesothelioma, a rare cause of malignant ascites

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    65. Roberts, F; Harper, CM; Downie, I; Burnett, RA
      Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma - A study of thirteen antibodies

      AJCP. American journal of clinical pathology
    66. Tirilomis, T; Busch, T; Sirbu, H; Dalichau, H
      Giant localized fibrous mesothelioma: an unusual large intrathoracic tumor

      LANGENBECKS ARCHIVES OF SURGERY
    67. Nasreen, N; Mohammed, KA; Dowling, PA; Ward, MJ; Galffy, G; Antony, VB
      Talc induces apoptosis in human malignant mesothelioma cells in vitro

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    68. Shah, KV
      Does SV40 infection contribute to the development of human cancers?

      REVIEWS IN MEDICAL VIROLOGY
    69. Pilatte, Y; Vivo, C; Renier, A; Kheuang, L; Greffard, A; Jaurand, MC
      Absence of SV40 large T-antigen expression in human mesothelioma cell lines

      AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    70. Jarvinen, K; Pietarinen-Runtti, P; Linnainmaa, K; Raivio, KO; Krejsa, CM; Kavanagh, T; Kinnula, VL
      Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    71. Monjanel-Mouterde, S; Frenay, C; Catalin, J; Boutin, C; Durand, A; Astoul, P
      Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions

      ONCOLOGY REPORTS
    72. Fizazi, K; Caliandro, R; Soulie, P; Fandi, A; Daniel, C; Bedin, A; Doubre, H; Viala, J; Rodier, JM; Trandafir, L; Le Chevalier, T; Cvitkovic, E; Armand, JP; Ruffie, P
      Combination raltitrexed (Tomudex (R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma

      EUROPEAN JOURNAL OF CANCER
    73. Whitaker, D
      The cytology of malignant mesothelioma

      CYTOPATHOLOGY
    74. Dejmek, A; Hjerpe, A
      Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis

      CYTOPATHOLOGY
    75. Sakamoto, K; Suzuki, H; Jojima, T
      Membranous glomerulonephritis associated with diffuse malignant pleural mesothelioma: Report of a case

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    76. Baas, P; van Meerbeeck, J; Groen, H; Schouwink, H; Burgers, S; Daamen, S; Giaccone, G
      Caelyx (TM) in malignant mesothelioma: A phase II EORTC study

      ANNALS OF ONCOLOGY
    77. Porcell, AI; De Young, BR; Proca, DM; Frankel, WL
      Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers

      MODERN PATHOLOGY
    78. Moran, CA; Wick, MR; Suster, S
      The role of immunohistochemistry in the diagnosis of malignant mesothelioma

      SEMINARS IN DIAGNOSTIC PATHOLOGY
    79. Shivapurkar, N; Wiethege, T; Wistuba, II; Salomon, E; Milchgrub, S; Muller, KM; Churg, A; Pass, H; Gazdar, AF
      Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations

      JOURNAL OF CELLULAR BIOCHEMISTRY
    80. Carbone, M
      Simian virus 40 and human tumors: It is time to study mechanisms

      JOURNAL OF CELLULAR BIOCHEMISTRY
    81. Bonomo, L; Feragalli, B; Sacco, R; Merlino, B; Storto, ML
      Malignant pleural disease

      EUROPEAN JOURNAL OF RADIOLOGY
    82. Bourdes, V; Boffetta, P; Pisani, P
      Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis - Environmental exposure to asbestos and mesothelioma

      EUROPEAN JOURNAL OF EPIDEMIOLOGY
    83. Langseth, H; Andersen, A
      Cancer incidence among male pulp and paper workers in Norway

      SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH
    84. McLaren, BR; Robinson, BWS; Lake, RA
      New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    85. Attanoos, RL; Dojcinov, SD; Webb, R; Gibbs, AR
      Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms

      HISTOPATHOLOGY
    86. Ordonez, NG
      Transitional cell carcinomas of the ovary and bladder are immunophenotypically different

      HISTOPATHOLOGY
    87. Delahunt, B; Eble, JN; King, D; Bethwaite, PB; Nacey, JN; Thornton, A
      Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour

      HISTOPATHOLOGY
    88. Gennaro, V; Finkelstein, MM; Ceppi, M; Fontana, V; Montanaro, F; Perrotta, A; Puntoni, R; Silvano, S
      Mesothelioma and lung tumors attributable to asbestos among petroleum workers

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    89. Levin, SM; Kann, PE; Lax, MB
      Medical examination for asbestos-related disease

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    90. Carbone, M; Rizzo, P; Pass, H
      Simian Virus 40: The link with human malignant mesothelioma is well established

      ANTICANCER RESEARCH
    91. Arrington, AS; Lednicky, JA; Butel, JS
      Molecular characterization of SV40 DNA in multiple samples from a human mesothelioma

      ANTICANCER RESEARCH
    92. Cristaudo, A; Powers, A; Vivaldi, A; Foddis, R; Guglielmi, G; Gattini, V; Buselli, R; Sensales, G; Ciancia, E; Ottenga, F
      SV40 can be reproducibly detected in paraffin-embedded mesothelioma samples

      ANTICANCER RESEARCH
    93. Ordonez, NG; Mackay, B
      Brenner tumor of the ovary: A comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder

      ULTRASTRUCTURAL PATHOLOGY
    94. Kramer, G; Gans, S; Rijnders, A; Leer, JW
      Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with (90)yttrium-silicate

      LUNG CANCER
    95. Ordonez, NG
      Epithelial mesothelioma with deciduoid features - Report of four cases

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    96. Hamilton, RS; Gravell, M; Major, EO
      Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus

      JOURNAL OF CLINICAL MICROBIOLOGY
    97. Lantuejoul, S; Laverriere, MH; Sturm, N; Moro, D; Frey, G; Brambilla, C; Brambilla, E
      NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas

      HUMAN PATHOLOGY
    98. Steele, JPC; Rudd, RM
      Malignant mesothelioma: predictors of prognosis and clinical trials

      THORAX
    99. Edwards, JG; Abrams, KR; Leverment, JN; Spyt, TJ; Waller, DA; O'Byrne, KJ
      Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

      THORAX
    100. Garcia-Lopez, MD; Barrera-Rodriguez, R
      Malignant mesothelioma: Clinical and radiological picture of 45 cases withor without exposure to asbestos.

      SALUD PUBLICA DE MEXICO


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 02:41:39